Kangmei Pharma | 600518 - Operating Expenses



Kangmei Pharma reported CNY1.25B in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Alaunos Therapeutics USD 759K 391K Dec/2024
Avita Medical AUD 28.36M 2.44M Dec/2024
Cspc Pharmaceutical CNY 5.22B 248.9M Mar/2025
Dianthus Therapeutics USD 35.12M 1.88M Jun/2025
Genomma Lab Internacional MXN 3.65B 198.93M Jun/2025
Hypermarcas BRL 1.51B 217.77M Jun/2025
Ionis Pharmaceuticals USD 312.21M 34.21M Jun/2025
IQVIA Holdings USD 3.46B 124M Jun/2025
Jiangsu Hengrui CNY 5.69B 570M Jun/2025
Kangmei Pharma CNY 1.25B 35.75M Jun/2025
Moderna USD 1.04B 113M Jun/2025
Organon & Co USD 1.27B 144M Jun/2025
Revvity USD 629.52M 36.99M Jun/2025
Sh Fosun Pharma CNY 9.31B 1.25B Jun/2025
Tectonic Therapeutic USD 22.33M 8.34M Jun/2025
Viatris USD 3.4B 2.88B Jun/2025
Wuxi Apptec CNY 7.28B 1.92B Jun/2025
Xeris Pharmaceuticals USD 67.06M 8.64M Jun/2025
Zz Pientze Pharmaceu 1.68B 272.39M Jun/2025